Leading applied research across a wide portfolio of cancer studies | quality of life | patient reported outcome measures (PROMs) | University of Leeds, UK
Interested in economic evaluations of using patient reported outcome measures (PROMs) in cancer? Check out our paper on the eRAPID intervention in chemotherapy. Findings indicate potential cost benefit when online symptom monitoring is added to usual care https://t.co/9xj3gyAG4X
....in recognition of her research into the long-term wellbeing and functioning of people affected by low-grade glioma. Read more here: https://t.co/PiNnp2Xu9b
We've been quiet on here so time for some updates- first off: Congratulations to our colleague @DrFlorienBoele for winning the European Association of Neuro-oncology @EANO Nurse & allied healthcare professionals research award 🏆
We are recruiting! Check out our vacancy: Research Fellow for @EORTC funded project exploring processes for selecting patient reported outcome (PRO) items for use in symptom monitoring within cancer trials and practice. ⭐️Deadline 26th Feb https://t.co/AYl0n113Gh ⭐️
Are you an NHS oncology nurse or a nurse working with cancer patients? Can you spare a few minutes to complete a survey exploring self-compassion & wellbeing at work? Click: https://t.co/pnWmJYQ6eX to help us understand your experiences. @BPOSUK@UKONSmember
Newly published study from @POGWeb: @DrFlorienBoele @DrKateAbsolom and colleagues on the reassurance gained from interval scanning for people living with high grade brain tumours despite the associated anxiety. Very interesting read.
Interested in the use of patient reported outcome measures in radiotherapy? Listen to our colleagues
@TrishHolch@GalinaVelikova2 discuss the future of ePROs in this great podcast. Thanks to @IJROBP for showcasing our research https://t.co/hXqgOHjRMc @LeedsMedHealth
This month we have several authors making the case for PROs.
March 2023 podcast "The Future of ePROs" with @KaitlynLapen@TrishHolch@GalinaVelikova2
AT: https://t.co/2Pm0nL5dC2
New Masterclass! "When Patience is a Failing" from @DeborahWBruner1
AT: https://t.co/CULAkxNhVE
Out today in @MASCC_JSCC funded by @yorkshirecancer "It made me feel part of the team, having my homework to do' women & specialist nurse experiences of remote follow‑up after ovarian cancer treatment https://t.co/9I9AH3kR0x @POGWeb @LeedsMedHealth @lshears_@MarieH2211
Now out! Results from our pilot study of eRAPID remote patient monitoring in radiotherapy. https://t.co/unNvtSA3OB We found:
▶️eRAPID was acceptable and feasible
▶️Online symptom report completion was particularly high in the prostate cancer group compared to the gynaecological
Our paper published online in BMC Cancer exploring feasibility of electronic patient-reported monitoring of symptoms during follow-up for ovarian cancer - available here ⬇️ https://t.co/jA0ssnSCCe @POGWeb
@LeedsMedHealth @yorkshirecancer@lshears_@MarieH2211
It's nearly time for the @BPOSUK 2022 conference! Good luck to the @POGWeb team members presenting talks and posters describing our work using online patient reported outcome interventions in cancer care https://t.co/le9VOXbFWL @DrFionaRKennedy@KathleenS_Kane
Important new @myESMO guidance now published: The role of patient-reported outcome measures in the continuum of cancer clinical care, co-authored by @POGWeb@Lorrwarr https://t.co/73q7eI6SW4
If you work in Paediatric, TYA #oncology and would like to pass our survey on to your colleagues, please email me at [email protected]
Everyone in the UK working in Paediatric, TYA Oncology needs to know about this survey, please help us spread the word! 🏳️🌈🏳️⚧️🇬🇧
In case you missed it- final report from our @NIHRresearch eRAPID programme grant is now published ‘Electronic self-reporting of adverse events for patients undergoing cancer treatment: the eRAPID research programme including two RCTs’ https://t.co/oAXgZTmeDu
We've been quiet on here for too long! Great to reignite our twitter profile to celebrate our colleague @pompili_cecilia following her long awaited PhD graduation on Monday. Congratulations Cecilia, we're very proud of all your achievements.